DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer. - Wikidata - awgldk - TriplyDB

DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.

DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.

http://www.wikidata.org/entity/Q36215003

about

The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex.TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.Therapeutic applications of TRAIL receptor agonists in cancer and beyond.Prognostic Biomarkers for Hodgkin Lymphoma.Harnessing mesenchymal stem cell homing as an anticancer therapy.LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect.Highly sensitive antibody-free μLC-MS/MS quantification of rhTRAIL in serum.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.

P2860

Q31814863-C58989EF-B605-4A33-AC43-CC2B1095616C Q35681794-C968A9CA-D33F-4661-A622-3963C575F61E Q36285296-09D9A767-4EC3-43AA-902D-3AF33F683C39 Q37114025-7B59D172-9C14-4556-B63A-8681B8BB2871 Q38588503-7DDDF81F-1BA2-4C26-96C6-268D28E901F0 Q38857484-B503DFB9-DE1E-45C9-A727-CC8EA56727E2 Q41949682-FB33D0EE-832A-4CA4-92B9-C2228C7C862B Q49567330-255BADC8-21BB-4D87-95BE-1667D08C2692 Q51373757-9F6A0DD3-128C-47E3-BFD3-071E1D7A2DAF Q51760860-AC26B6A4-EC21-442B-88BE-A06D5C6ED5AE

P2860

DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.

http://www.wikidata.org/entity/Q36215003

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@ast

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@en

type

label

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@ast

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@en

prefLabel

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@ast

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@en

P1433

Q36215003-E7545CC9-B077-45C5-B01E-FCD128F47944

P1476

Q36215003-F54615E7-6FD0-4F44-BD41-1B69C9B8B3A2

P2093

Q36215003-1A18281F-538F-44EB-B73E-ADB58B6D8BE0

Q36215003-3B69D473-EF9B-46AB-B87B-371A0A3733B3

Q36215003-A23AA86B-31BB-4C63-B53A-1BCCFC706C38

P2860

Q36215003-00674193-8490-48B1-A194-18ABB209A839

Q36215003-0A9413B8-ED32-4CA8-95B5-0980030AB7EC

Q36215003-12FF9347-2E46-462A-8CA8-D9DEFF34652C

Q36215003-16B0A0C5-1CC6-4359-82AA-9E9CAE671F16

Q36215003-1F1FDE22-2F4D-4C72-8685-E8107C3D681C

Q36215003-218AE748-E481-4566-8E38-1FE28F42E401

Q36215003-24E4D8E0-1D52-488F-AA78-6EBD31A859B3

Q36215003-26201588-1E15-4235-8EC9-5867B40CBF07

Q36215003-28AF71C0-F054-4AFD-9D3E-60F9CA0C29CD

Q36215003-2D66CC3D-9D86-4428-8A69-0DD57BE0EBCC

P304

Q36215003-B463244A-60E3-471D-A32B-6D33D05C49A9

P31

Q36215003-AD50DDB3-9858-412F-A280-17E31B71372E

P356

Q36215003-B1686354-F6D2-4F46-8F44-603D557A327C

P433

Q36215003-9F23C564-2622-47E1-AD8F-2BF9D6694CFB

P478

Q36215003-19D2CAEB-FACA-49E3-95ED-1CF4417B0B1B

P50

Q36215003-26F85A56-B6AA-4879-BAB1-1275B56A652D

Q36215003-90715C8C-7C4C-470E-BA6D-62DC224B8A4A

Q36215003-EA0FC8AB-CA19-4C00-8A1D-DDB0159B4548

P577

Q36215003-869A30F3-1DC3-4C9F-AA7C-32599D44DEDA

P5875

Q36215003-DA8EC8D3-FA34-4976-8240-248131A66B10

P698

Q36215003-89179392-E353-4361-94B5-0C6A5CD5AF47

P932

Q36215003-35825A89-5BB3-4F0B-BFD4-455A6A21847E

P356

15384047.2014.972183

P1433

Cancer Biology and Therapy

P1476

DR4 specific TRAIL variants ar ...... pe TRAIL in pancreatic cancer.

@en

P2093

Rui Yu

http://www.w3.org/2001/XMLSchema#string

Stella Maris Albarenque

http://www.w3.org/2001/XMLSchema#string

Wim J Quax

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of a new member of the TNF family that induces apoptosis

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity

A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

Following a TRAIL: update on a ligand and its five receptors

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

Random mutagenesis by error-prone PCR.

P304

1658-1666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/15384047.2014.972183

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Ralf Michael Zwacka

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269282980

http://www.w3.org/2001/XMLSchema#string

P698

25482930

http://www.w3.org/2001/XMLSchema#string

P932

4623120

http://www.w3.org/2001/XMLSchema#string